MedTrace Logo

Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma

NCT06115408 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-16

No results posted yet for this study

Summary

This 2 arm randomized clinical trial will assess the impact of Dienogest and N-Acetyl Cysteine on volume reduction of uterine leiomyoma

Conditions

  • Uterine Leiomyoma

Interventions

DRUG

Dienogest 2 MG

Clinical trial

DRUG

N-acetyl cysteine

Clinical trial

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Amr Mahmoud, lecturer · Ain Shams University

  • Ahmed mohamed mamdouh, assisstant professor · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06115408 on ClinicalTrials.gov